HT
AMED

HAP Trading’s Amedisys AMED Stock Holding History

HAP Trading’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-22,300
Closed -$6.31K – 844
2025
Q2 		$6.31K Sell
22,300
-107,800
-83% -$10.2M ﹤0.01% 676
2025
Q1 		$293K Sell
130,100
-15,000
-10% -$1.38M 0.03% 254
2024
Q4 		$665K Buy
145,100
+95,000
+190% +$8.72M 0.06% 170
2024
Q3 		$4.11K Sell
50,100
-39,900
-44% -$3.89M ﹤0.01% 633
2024
Q2 		$148K Buy
90,000
+40,000
+80% +$3.71M 0.02% 324
2024
Q1 		$37.5K Hold
50,000
– – ﹤0.01% 462
2023
Q4 		$35K Buy
+50,000
New +$4.67M 0.01% 502
2014
Q1 		– Sell
-10,600
Closed -$5K – 994
2013
Q4 		$5K Buy
+10,600
New +$171K ﹤0.01% 1077

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

HAP Trading's AMED Position: Q2 2025 in Review

HAP Trading sold out of Amedisys (AMED) in Q2 2025, closing a stake of 32,422 shares — an estimated $3.07M sold.

HAP Trading first reported a position in AMED in Q1 2025 and held it in 1 quarter. The position peaked at $3M in Q1 2025. 320 funds tracked by Wall St. Rank hold AMED as of Q2 2025.

  • HAP Trading reported no remaining Amedisys position as of Q2 2025 after selling out during the quarter.
  • HAP Trading sold 32,422 Amedisys shares in Q2 2025, an estimated $3.07M.
  • HAP Trading first reported a position in Amedisys in Q1 2025 and held it in 1 quarter.
  • HAP Trading's Amedisys position peaked at $3M in Q1 2025.
  • 320 funds tracked by Wall St. Rank held Amedisys as of Q2 2025.

Based on HAP Trading's 13F filing for Q2 2025, filed 13 Aug 2025.